The Novel Coronavirus Response and Coordination Centre has announced that a 22-year-old man who received his second BioNTech mRNA jab on Wednesday has been diagnosed with myocarditis.
A statement by the centre on Saturday said that the case, which was reported on Friday and has been classified as a “serious” post-vaccination adverse event, has been transferred to the Health Bureau’s (SSM) special working group tasked with assessing serious adverse events after COVID-19 vaccinations.
Myocarditis is the inflammation of the heart muscle.
According to the statement, the man came down with a chest pain, headache and fever on Friday morning, because of which he went to the public Conde de São Januário Hospital Centre’s emergency service branch in Taipa – which is located next to the University Hospital run by the private Macau University of Science and Technology (MUST) – on the same night, where he was diagnosed with acute myocarditis.
The statement said that the man was then transferred to the public hospital on the peninsula for treatment. After being treated, the statement said, the man’s chest pain eased on Saturday.
